Romano Gary 4
4 · Passage BIO, Inc. · Filed Mar 17, 2021
Insider Transaction Report
Form 4
Romano Gary
Chief Medical Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2021-03-15−10,000→ 300,821 totalExercise: $8.07Exp: 2029-10-23→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2021-03-15$8.07/sh+10,000$80,700→ 10,000 total - Sale
Common Stock
2021-03-15$21.86/sh−1,617$35,350→ 0 total - Sale
Common Stock
2021-03-15$20.95/sh−8,383$175,662→ 1,617 total
Footnotes (4)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $21.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.65 to $22.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F4]The option vests as to 25% of the total shares on August 20, 2020 and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on August 20, 2023 subject to the reporting person's provision of service to the issuer on each vesting date. The option provides for an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.